http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11247994-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a6f422b091ba12ea61d4adbf1b0e8e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-173 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-24 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-24 |
filingDate | 2021-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ba6e8a9b4bead33205c9695766d4cb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf8c958e552a9c3dceb68a7710deeaed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82367c8e8dff3b2c0ced1d0ca9a2552c |
publicationDate | 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-11247994-B2 |
titleOfInvention | 6-dithio-substituted-2′-deoxyguanosine compound, preparation method thereof and use thereof |
abstract | The present invention provides a 6-dithio-substituted-2′-deoxyguanosine compound and a preparation method thereof and use thereof in anti-tumor drugs. According to the present invention, a series of brand-new thioredoxin-1 (Trx-1) inhibitors are designed and synthesized by using 2′-deoxyguanosine as a structure mother nucleus. The compound according to the present invention is a structure of formula I, and Trx-1 activity inhibition testing is performed on the type of compounds, showing apparent inhibitory activity. It is indicated from in vitro and vivo researches that these compounds show significant anti-tumor effects on multiple types of tumors, can be applied to drugs for tumors related to human body cell proliferation, and provide a new path for the research of anticancer drugs. |
priorityDate | 2018-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 325.